Responses
Immune cell therapies and immune cell engineering
Original research
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
